RAPT Therapeutics, Inc. (RAPT) EPS (Basic) (2020 - 2024)
RAPT Therapeutics' EPS (Basic) history spans 5 years, with the latest figure at -$1.22 for Q4 2024.
- For Q4 2024, EPS (Basic) fell 50.62% year-over-year to -$1.22; the TTM value through Dec 2024 reached -$6.51, down 113.44%, while the annual FY2024 figure was -$3.19, 4.59% down from the prior year.
- EPS (Basic) for Q4 2024 was -$1.22 at RAPT Therapeutics, up from -$3.79 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.51 in Q2 2020 and bottomed at -$3.79 in Q3 2024.
- The 5-year median for EPS (Basic) is -$0.66 (2022), against an average of -$0.84.
- The largest annual shift saw EPS (Basic) increased 1.59% in 2022 before it plummeted 362.2% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.52 in 2020, then decreased by 17.31% to -$0.61 in 2021, then fell by 6.56% to -$0.65 in 2022, then dropped by 24.62% to -$0.81 in 2023, then plummeted by 50.62% to -$1.22 in 2024.
- Per Business Quant, the three most recent readings for RAPT's EPS (Basic) are -$1.22 (Q4 2024), -$3.79 (Q3 2024), and -$0.71 (Q2 2024).